About: Treatment of age-related macular degeneration

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Treatment of age-related macular degeneration Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 19 July 2013

Attributes	Values
rdf:type	Item
description	наукова стаття, опублікована в липні 2013 (uk) article scientifique publié en 2013 (fr) scientific article published on 19 July 2013 (en) artículu científicu espublizáu en xunetu de 2013 (ast)
publication date	wds:Q87121162-942FCBBD-4BEC-4098-9E85-CB34A0CB8449
publication date	2013-07-19 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q87121162-9EB578C6-DA4D-46D8-B501-8A366F223D65
language of work or name	English
cites work	wds:Q87121162-007A8FD3-CDF1-4CA8-999F-E660CBB97C10 wds:Q87121162-0CA53DF2-85D8-4C82-B506-FE1602DB825A wds:Q87121162-1EE41694-9C35-4AAB-81C6-02413FE5FE3F wds:Q87121162-3549845F-5101-48AD-9F67-04E297503E7F wds:Q87121162-42B3B779-9419-451A-953B-CD35043F6C95 wds:Q87121162-6CC05FFC-28FC-47BE-91C5-EC52BFB6E69B wds:Q87121162-7DE91553-118E-4D64-86BD-4CDDFAE9F356 wds:Q87121162-8C003496-C654-4AA2-BDBF-3D8BAAA926DB wds:Q87121162-D7B46FC6-E5C7-4593-9A29-8F7E36F3C781 wds:Q87121162-E5710C00-1851-458C-B68A-CABE3136FE1C wds:Q87121162-EB567CAE-6954-4AFC-A00D-D1DC6B782507 wds:Q87121162-EB76F619-7F81-48CE-AA54-AC7D0C77A01A wds:Q87121162-FA9EFDEB-EA36-4D95-B0DA-39C06D0D0A7C wds:Q87121162-FB07FF29-3F1C-490F-8879-BE86A55C951D wds:Q87121162-FD46198A-18EE-4C64-9C77-76941215BE5C
cites work	Ranibizumab and bevacizumab for neovascular age-related macular degeneration Ranibizumab for neovascular age-related macular degeneration Ranibizumab versus verteporfin for neovascular age-related macular degeneration. Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration Age-related macular degeneration Emerging evidence concerning systemic safety of anti-VEGF agents--should ophthalmologists be concerned? Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis Clinical update: new treatments for age-related macular degeneration Age-related macular degeneration and risk for stroke Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting Changing trends of blindness: the initial harvest from translational public health and clinical research in ophthalmology
author name string	wds:Q87121162-35491055-6030-43DC-A7BC-96759875462D wds:Q87121162-D1760D5C-545E-414A-AF57-AAB735635774
author name string	Tien Y Wong Chui Ming Gemmy Cheung
rdfs:label	Treatment of age-related macular degeneration (en)
skos:prefLabel	Treatment of age-related macular degeneration (en)
name	Treatment of age-related macular degeneration (en)
title	wds:Q87121162-5E62B192-6058-460B-8417-ACD3AE11B9DA
title	Treatment of age-related macular degeneration (en)
page(s)	wds:Q87121162-954EF425-30D8-42D1-A77D-E603B665758D
page(s)	1230-1232
instance of	wds:Q87121162-CB6A06BF-5FDE-4C2C-BB53-EF7F59BFFBC1
instance of	scholarly article
main subject	wds:Q87121162-FAEF61D6-5806-4167-9D35-1CDCE32E00FE
main subject	macular degeneration
PubMed ID	wds:Q87121162-0262BE90-050D-48BF-8B8B-A83EB8803CCA
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23870812
PubMed ID	23870812
published in	wds:Q87121162-386AE4AC-12F9-4ED3-B416-142018AEDDE9
published in	The Lancet
issue	wds:Q87121162-3D8880E2-A721-483B-9A2E-6EB2645E9C4D
volume	wds:Q87121162-5F5BAA79-7CFF-47AC-897C-D3BF9EF95691
issue	9900
volume	382
DOI	wds:Q87121162-9FA3017F-4FC9-4E52-9962-937FB40E6380
DOI	http://dx.doi.org/10.1016/S0140-6736(13)61580-9
DOI	10.1016/S0140-6736(13)61580-9
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q87121162
is cites work of	Identification of age-related macular degeneration related genes by applying shortest path algorithm in protein-protein interaction network Nutritional and Lifestyle Interventions for Age-Related Macular Degeneration: A Review Systemic adverse events after intravitreal bevacizumab versus ranibizumab for age-related macular degeneration: a meta-analysis EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB IN ASIAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Subgroup Analyses From the View Trials. Pattern of adverse events induced by aflibercept and ranibizumab: A nationwide spontaneous adverse event reporting database, 2007-2016
is cites work of	wds:Q47244077-C3EA568E-9832-477E-AF56-12CDDB07F9C5 wds:Q34444212-8C3A8C2F-F0F3-40EC-8C51-37A967C9C7B1 wds:Q37426611-80F4DA52-5F2F-49F7-A833-E42D7FA076A6 wds:Q92637470-3D4C1264-6C1E-4DDC-B833-52CED0E7BA16 wds:Q37592954-7B93F931-EDDB-4F95-8ECB-77B5EB979543

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software